What is Nordic protocol, a treatment routine for rare and aggressive cancers?
While cancer always seems to be undefeatable, a special treatment routine is getting more attention. Australian comedian Magda Szubanski recently spoke about a special treatment she will be opting for after being diagnosed with stage four Mantle Cell Lymphoma (MCL), which is a rare and aggressive form of blood cancer.
'It's serious, but I've started one of the best treatments available (the Nordic protocol),' the 64-year-old told the media. Mantle Cell Lymphoma (MCL) is a rare and aggressive type of non-Hodgkin lymphoma that starts in the "mantle zone" of lymph nodes. It often spreads quickly to other parts of the body like the bone marrow, spleen, and gastrointestinal tract. Symptoms can include swollen lymph nodes, fatigue, weight loss, and night sweats.
Because it's fast-growing, MCL typically requires immediate and intensive treatment, including chemotherapy, immunotherapy, and sometimes stem cell transplants. While it's challenging to cure, newer targeted therapies, like Nordic protocol, are offering hope and better outcomes for many patients living with MCL.
What is Nordic protocol?
The Nordic Protocol is a specific type of cancer treatment plan, mostly used for certain blood cancers, especially lymphomas like Burkitt lymphoma and leukemias in kids and young adults.
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
40대 이상이고 PC가 있으세요? 그럼 이 게임을 정말 좋아하실 거예요!
Sea of Conquest
플레이하기
Undo
It's called 'Nordic' because it was originally developed and used in—you guessed it—Nordic countries like Sweden, Denmark, Norway, Finland, and Iceland.
Now, this isn't some fancy herbal remedy or treatment. It's hardcore, hospital-based chemotherapy—a very structured, carefully planned combo of cancer-killing drugs designed to wipe out fast-growing cancer cells in the blood and lymph system.
So what makes it special?
The Nordic Protocol is intense.
It uses a mix of powerful chemo drugs, often including things like cyclophosphamide, methotrexate, cytarabine, and doxorubicin (each one does a different job).
It's very targeted and time-sensitive. The Nordic Protocol is known for being aggressive but precise, which means it's hard on the cancer but tries to be as manageable as possible for the patient. Because it was created for young patients, doctors try to balance effectiveness with fewer long-term side effects.
Does it work?
Yup, it's got a pretty good track record—high cure rates for certain lymphomas, especially when caught early. It's widely respected around the world, especially in pediatric oncology circles.
That said, it's not a one-size-fits-all plan. Doctors customize it based on things like your age, how advanced the cancer is, and how your body responds to early treatments.
One step to a healthier you—join Times Health+ Yoga and feel the change
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Indian Express
4 hours ago
- Indian Express
After 6 years, intervention by 2 ministries and Delhi HC, Australian child born in India through surrogacy gets exit visa nod
It took six years and multiple back-and-forths between two key Union ministries and the Delhi High Court to ensure an exit visa for a six-year-old child born through surrogacy to Indian-origin Australian citizens in 2019, before the Surrogacy Act came into force in 2022. In the absence of clarity among the two ministries – Ministry of Health and Family Welfare, the Ministry of Home Affairs (MHA) – and after several 'procedural hurdles', the MHA on May 21 directed its Bureau of Immigration to issue an exit visa to the child, subject to payment of late fees for overstay beyond 90 days. The MHA then informed the high court of its decision, recorded in an order by Justice Sachin Datta on May 26. An exit visa is permission granted to a foreigner to leave India in the absence of a valid visa or entry into a country. In the case of the child, born in India and staying here since, his passport as an Australian citizen had no entry stamp to India, thus requiring an exit visa to leave the country. The MHA's decision came after the child's father, an Australian citizen, moved the Delhi High Court earlier this year seeking directions to issue an exit visa for his child, which he had applied for nearly two years ago on April 28, 2023. He is expected to fly out later this month to Australia with his son, say his lawyers Rakesh Kumar and Puneet Kumar. The child's parents are Australian citizens with Overseas Citizen of India (OCI) registration. Born in 2019 in India, the child obtained Australian citizenship in January 2023 following a court order and after complying with the necessary processes. The child's mother, who suffers from Crohn's disease, had decided to go for a gestational surrogacy in 2019 in compliance with Indian Council of Medical Research (ICMR) Guidelines, 2005, which required the execution of a surrogacy agreement with the surrogate mother and intended parent. This was prior to the Surrogacy Regulation Act, 2021, which only came into effect in January 2022. The baby was born in Indore in June 2019, and while his mother died in 2021 due to COVID-19, by January 2023, the boy's father obtained the child's Australian citizenship along with a Mumbai civil court order granting him permission to take the minor from India to Australia. Days after issuing an Australian passport to the child in April 2023, his father applied for an exit visa on behalf of his son through the e-portal of the Foreigners Regional Registration Office (FRRO). In June 2024, the application was shown as 'completed' on the portal but with directions to 'wait for further instructions.' However, on August 14, 2024, the Ministry of Health and Family Welfare (MoHFW) issued an office memorandum (OM), informing the MHA that as per provisions of the Surrogacy Act 2021 and its Rules 2022, foreign nationals are not eligible to avail surrogacy services in India and, for a couple of Indian origin (OCI cardholders), they have to obtain a certificate of recommendation from the National Board formed under the Act before availing such surrogacy treatment. The office memorandum also sought documents from the father with respect to the surrogacy, by way of clarification. In further bureaucratic back and forth, in November 2024, the MHA sought that the father submit a No-Objection Certificate (NOC) from the MoHFW, and days later, the MoHFW telephonically informed the father that they are not responsible for issuing any such NOC. The petitioners – father and son – argued that the Surrogacy Act and its Rules cannot apply retrospectively as it was not in place when the child was born, and had termed the MoHFW's office memorandum of August 2024, directing them to submit proofs of requisite permissions as per the Act, as 'illegal'. When the case was first taken up by Justice Datta in April, it was argued that with the child obtaining admission in a school in Sydney for academic year 2025, the delay in the grant of visa is disrupting the child's education and prolonged absence from regular classes at school has led to issuance of absentee notice by the school, making him likely to suffer cancellation of his admission. At the time of the court hearing, the Union government was granted time to obtain instructions. On May 26, informing the court, the Union government submitted that 'during the year 2015, since there was no regulation on surrogacy in India, MHA had imposed restriction on grant of visa/exit permit to children born out of surrogacy to foreign nationals (including OCI cardholders).' 'Further, during the year 2021, the Surrogacy (Regulation) Act, 2021 was introduced by the Ministry of Health & Family Welfare and Surrogacy Rules were notified in 2022. The Surrogacy Rules permitted surrogacy only for Indian nationals and OCI cardholder parents. However, in the instant case, surrogacy was commissioned…before commencement of Surrogacy Regulation/law in India in violation of MHA guidelines,' the government told the high court. It added, 'Considering the peculiar circumstances of the case and in the interest of the child, the matter was examined in this Ministry. It has been decided to grant exit permit to the Petitioner No.1 after regularising his overstay period by charging appropriate financial penalty.' Taking the MHA's submission on record, Justice Datta thus directed that following payment of the necessary dues, the exit visa be granted to the child expeditiously, and disposed of the matter.
Time of India
11 hours ago
- Time of India
Millets are no modern fad: Bronze Age humans consumed this gluten-free grain, here's why
Scientists dig up how diet changed and transformed society during the Bronze Age. People these days are swapping wheat with a more nutritious grain - millet. But this isn't just another modern health trend. Millets have been a staple in the diet for centuries. A recent study has found that millet was already revolutionizing diets as far as the Bronze Age. People from the Tumulus culture, the ones who lived in Central Europe during the Middle Bronze Age, were believed to be mostly pastoralists. However, a recent study has challenged this long-held belief and given insight into the shifts seen around 1500 BC, including lifestyle changes in Central European history. The findings of the bioarchaeological investigation of the Bronze Age cemetery of Tiszafüred-Majoroshalom, led by an international research team, are published in the journal Scientific Reports . Around 1500 BC, there were radical changes in people's lives: they ate and lived differently, and the social system was also reorganized. How diet changed Nitrogen isotope studies show that during the Middle Bronze Age, people had a more diverse diet, and social differences were clear, especially in who had access to animal protein. By the Late Bronze Age, these differences faded, and diets became more uniform but less nutritious. Broomcorn millet was introduced The carbon isotope analyses found that people consumed millet. As the plant can be grown quickly and has a high energy content, it became quite a popular option towards the beginning of the Late Bronze Age. Yes, that's right. Millets are no modern trend; they have been part of our diets for centuries. The data from the Tiszafüred Bronze Age cemetery indicate the earliest known consumption of millet in Europe. Stay ready with these 7 essential medical gadgets as COVID cases rise Nutritional value of millets Millets have numerous health benefits. Grown in India, Nigeria, and other Asian and African countries, the small round grains are gluten-free and have high amounts of protein, fiber, and antioxidants. One cup (174 grams) of cooked millet contains: Calories: 207 Carbs: 41 grams Fiber: 2.2 grams Protein: 6 grams Fat: 1.7 grams Phosphorus: 25% of the Daily Value (DV) Magnesium: 19% of the DV Folate: 8% of the DV Iron: 6% of the DV How diet changed social relations Social relationships changed during the Late Bronze Age. People stopped living in long-established, tightly organized tell-settlements and instead lived in smaller, more spread-out communities. This shift led to a looser and less structured social system, which also showed up in their diets. The analysis of the teeth and isotope tests revealed that people ate much less animal protein than before. This goes against the earlier belief that the Tumulus culture mainly focused on animal husbandry. Millets are today opted for their nutritional value and also as a gluten-free option, especially for those with gluten intolerance. One step to a healthier you—join Times Health+ Yoga and feel the change
Hans India
12 hours ago
- Hans India
Scientists develop real-time genome sequencing to combat superbug
Australian scientists have made a breakthrough in combating Staphylococcus aureus, commonly known as golden staph - a superbug. The world-first initiative has demonstrated that real-time genome sequencing during severe infections allows doctors to quickly identify resistance mutations, and personalise treatment, Xinhua news agency reported. It will also help curb the spread of antibiotic resistance, said researchers from the Melbourne-based Peter Doherty Institute for Infection and Immunity (Doherty Institute). Collaborating with seven local hospitals, scientists from the Doherty Institute said that traditionally, hospital laboratories identify bacteria using standard tests that reveal only the species type, offering limited insight into antibiotic resistance or genetic changes. In contrast, genome sequencing provides a comprehensive genetic profile, uncovering mutations that can influence how bacteria respond to treatment. Previously, research into bacterial evolution was typically carried out retrospectively, often years after patients had completed treatment. In contrast, this new method enables clinicians to monitor bacterial changes in real-time, providing immediate and actionable insights for patient care, according to the study published in Nature Communications. Comparing golden staph samples from patients at the start of infection and at treatment failure, researchers found that in a third of cases, the bacteria developed mutations making standard antibiotics ineffective, said lead author Stefano Giulieri at the Doherty Institute and the University of Melbourne. 'In one case, after initially controlling a golden staph infection, the patient returned to the hospital two months after stopping antibiotics,' Giulieri said. Giulieri added that resistance increased 80-fold within two months, but genomic insights enabled clinicians to successfully adapt treatment and cure the infection. These findings represent a major step toward targeted therapy for bacterial infections and open the door to future clinical trials that could make this approach standard practice in hospitals worldwide, said the researchers.
